General Information
Product name
Tropicacyl (Tropicamide Ophthalmic Solution USP, 0.5%)
Manufacturer Name
Akorn Incorporated
Icons in SDS
Company Information
company name
Akorn Incorporated
Section 2
Health hazards
Carcinogenicity: (NTP) No (IARC) No (OSHA) No Eye: May cause irritation and hypersensitivity (anaphylactic) in some individuals. Can cause temporary light sensitivity and increased intraocular pressure. Overdosage (systemic toxicity) is manifested by headache, blurred vision, a rapid and irregular pulse, psychotic reactions, unusual drowsiness and dry mouth. Severe reactions are manifested by low blood pressure (hypotension) with progressive respiratory depression. The main symptoms are drowsiness leading to coma. Once the drug is withdrawn, the mechanism of overdosage is self‐limiting. Skin: May cause irritation and hypersensitivity in some individuals. Toxic systemic effects may be induced by skin contact. Ingestion: May cause irritation, vomiting, diarrhea and hypersensitivity in some individuals. Ingestion of tropicamide may induce systemic toxicity effects. Inhalation: May cause irritation and hypersensitivity in some individuals.
Potential chronic health
May cause irritation. May cause hypersensitivity. Severe reactions are manifested by hypotension with progressive respiratory depression. Target Organs: Eyes, central nervous system, respiratory and digestive tract 1 of 5
Medical Conditions Generally Aggravated by Exposure
Hypersensitivity to any of the components of the product. Animal reproduction studies have not been performed with tropicamide. It is also not known whether tropicamide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Tropicamide should be given to pregnant woman only if clearly needed.
